On February 3, the Dr. Agarwal Healthcare IPO allotment status will be confirmed. The webpage of Kfin Technologies Ltd. allows investors to view their current status. Retail, NIIs, and QIBs all responded well to the IPO. Refunds for failed applicants will begin on February 4 and shares will be awarded on February 5.
Status of Dr. Agarwal Healthcare’s IPO share allocation: On Monday, February 3, the Dr. Agarwal Healthcare IPO share allocation will be finalized. Investors who submitted applications for the Dr. Agarwals IPO can monitor the Dr. Agarwal Healthcare IPO allotment status on the Kfin Technologies Ltd. registrar’s webpage. Subscriptions for the Temasek Holdings and TPG-backed company’s IPO went live on Wednesday, January 29, and concluded on Friday, January 31.
The issue had a respectable amount of response at the end of the final bidding day from retail investors (41%), qualified institutional buyers (QIBs) (4.64 times), and non-institutional investors (NIIs) (40%). According to BSE statistics, Dr. Agarwal’s IPO subscription status was 1.55 times on the third day.
By understanding the principles of allocation, investors may determine their share distribution and percentage. The number of shares available must be considered while confirming the IPO allotment status. Should applicants be unsuccessful in obtaining shares, the business will initiate the process of issuing refunds. The individual’s demat account will be credited with the allotted shares.
On Monday, February 3, the refund process will also start for those who were not given shares. Shares allotted to individuals will be deposited into their demat accounts on the same day.
The IPO listing date for Dr. Agarwal Healthcare is set on Tuesday, February 4.
How can check the registrar’s portal for Dr. Agarwal Healthcare’s IPO allotment status?
You may check your Dr. Agarwal Healthcare IPO allotment status online right now on the website of the IPO registrar, Kfin Technologies Ltd., if you applied for the Dr. Agarwals IPO.
Step 1: You can use one of five URLs to verify the status after clicking the supplied link.
Upon selecting one of the five URLs, proceed to the “Select IPO” dropdown option and choose “Dr Agarwal IPO.”
Step 3: Enter your PAN, Demat account number, or application number to see the status.
Step 4: Enter the application number first, followed by the captcha code, if this option is selected. Press “Submit.”
Provide the account information and the captcha code if you choose the Demat Account option. Press “Submit.”
Enter both your PAN number and the captcha code for the third choice, PAN. Press “Submit.”
How can I find out the BSE’s Dr. Agarwal Healthcare IPO allotment status?
First Step:
Go to the allocation page on the BSE’s official website: https://www.bseindia.com/investors/appli_check.aspx
Select ‘Equity’ under ‘Issue Type’ in step two.
Step 3: Choose the IPO by selecting ‘Issue Name’ from the drop-down option.
Step 4: Enter your PAN, or application number.
How can I find out the NSE’s Dr. Agarwal Healthcare IPO allotment status?
First Step:
Go to https://www1.nseindia.com/products/dynaContent/equities/ipos/ipo_login.jsp, the official website of the NSE.
Step 2: On the NSE website, select the “Click here to sign up” option to register with PAN.
Step 3: Enter your user name, password, and captcha code.
Step 4: Verify the status of your IPO allocation on the next page that appears.
Today’s Dr. Agarwal Healthcare IPO GMP
According to investorgain.com, Dr. Agarwal’s IPO GMP today, or grey market premium, was ₹0, meaning that shares were selling at their issue price of ₹402 with no premium or discount on the grey market.
Given the performance of the grey market throughout the last nine sessions, the IPO GMP is now declining and seems to be headed for more falls. According to specialists at investorgain.com, the lowest GMP recorded is 0.00, and the highest is ₹54.
Investors’ willingness to pay more than the issue price is shown by the “grey market premium.”
Disclaimer: business connect india does not endorse the opinions and suggestions expressed here; rather, they represent the opinions of individual analysts, experts, and brokerage firms. Before making any financial decisions, we suggest you to consult with qualified professionals.
